文献速递流行病学与生物统计

先天畸形儿童长期生存:基于人群研究的系统综述与荟萃分析

Long-term survival of children born with congenital anomalies: A systematic review and meta-analysis of population-based studies.
PubMed 文献 · PLoS Med · 2020-09-28

该系统综述与荟萃分析纳入1995至2020年发表的基于人群研究,评估特定重大先天畸形患儿1岁后长期生存情况。55项研究(367,801例活产)被叙述性总结,41项研究(54,676例)纳入荟萃分析,覆盖1970至2015年出生年份。脊膜膨出、食管闭锁、胆道闭锁、膈疝、腹裂及合并先天性心脏病的唐氏综合征患儿生存率随时间显著改善,而脑膨出和胆道闭锁自体肝生存未见改善。

要点

  • 特定重大先天畸形患儿长期生存率近几十年显著改善。
  • 脑膨出及胆道闭锁自体肝生存未见随时间改善。
  • 合并其他结构畸形、低出生体重和较早出生年份是生存降低的预测因素。

核心结论

  • 特定重大先天畸形患儿长期生存率近几十年显著改善,并预测2020年出生者至20岁的生存估计。

研究设计与样本

  • 系统综述与荟萃分析,检索7个电子数据库1995年1月1日至2020年4月30日发表的英文同行评议原创基于人群研究。
  • 纳入报告重大先天畸形患儿1岁后长期生存且随访从出生开始的研究,排除先天性心脏缺陷研究。
  • 55项研究(n=367,801例活产)叙述性总结,41项研究(n=54,676例)纳入荟萃分析,覆盖1970至2015年出生年份。

主要发现

  • 脊膜膨出(n=7,422)、食管闭锁(n=6,303)、胆道闭锁(n=3,877)、膈疝(n=6,176)、腹裂(n=4,845)、合并先天性心脏病的唐氏综合征(n=22,317)生存率随时间显著改善。
  • 脊膜膨出每10年出生年份的生存合并OR=1.34(95%CI 1.24-1.46,p<0.001)。
  • 食管闭锁OR=1.50(95%CI 1.38-1.62,p<0.001),胆道闭锁OR=1.62(95%CI 1.28-2.05,p<0.001),膈疝OR=1.57(95%CI 1.37-1.81,p<0.001),腹裂OR=1.24(95%CI 1.02-1.5,p=0.029),合并先天性心脏病的唐氏综合征OR=1.99(95%CI 1.67-2.37,p<0.001)。
  • 脑膨出(n=1,562)生存无改善(OR=0.98,95%CI 0.95-1.01,p=0.19),胆道闭锁自体肝生存无改善(OR=0.96,95%CI 0.88-1.03,p=0.26)。
  • 合并其他结构畸形、低出生体重和较早出生年份是任何先天畸形类型生存降低的最常见预测因素。

临床怎么用

  • 可为特定先天畸形患儿家庭提供长期生存咨询,并规划专科医疗、社会和教育服务。

局限性

  • 荟萃分析纳入研究数量少且队列规模小,限制了模型预测能力,导致置信区间宽。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Following a reduction in global child mortality due to communicable diseases, the relative contribution of congenital anomalies to child mortality is increasing. Although infant survival of children born with congenital anomalies has improved for many anomaly types in recent decades, there is less evidence on survival beyond infancy. We aimed to systematically review, summarise, and quantify the existing population-based data on long-term survival of individuals born with specific major congenital anomalies and examine the factors associated with survival. METHODS AND FINDINGS: Seven electronic databases (Medline, Embase, Scopus, PsycINFO, CINAHL, ProQuest Natural, and Biological Science Collections), reference lists, and citations of the included articles for studies published 1 January 1995 to 30 April 2020 were searched. Screening for eligibility, data extraction, and quality appraisal were performed in duplicate. We included original population-based studies that reported long-term survival (beyond 1 year of life) of children born with a major congenital anomaly with the follow-up starting from birth that were published in the English language as peer-reviewed papers. Studies on congenital heart defects (CHDs) were excluded because of a recent systematic review of population-based studies of CHD survival. Meta-analysis was performed to pool survival estimates, accounting for trends over time. Of 10,888 identified articles, 55 (n = 367,801 live births) met the inclusion criteria and were summarised narratively, 41 studies (n = 54,676) investigating eight congenital anomaly types (spina bifida [n = 7,422], encephalocele [n = 1,562], oesophageal atresia [n = 6,303], biliary atresia [n = 3,877], diaphragmatic hernia [n = 6,176], gastroschisis [n = 4,845], Down syndrome by presence of CHD [n = 22,317], and trisomy 18 [n = 2,174]) were included in the meta-analysis. These studies covered birth years from 1970 to 2015. Survival for children with spina bifida, oesophageal atresia, biliary atresia, diaphragmatic hernia, gastroschisis, and Down syndrome with an associated CHD has significantly improved over time, with the pooled odds ratios (ORs) of surviving per 10-year increase in birth year being OR = 1.34 (95% confidence interval [95% CI] 1.24-1.46), OR = 1.50 (95% CI 1.38-1.62), OR = 1.62 (95% CI 1.28-2.05), OR = 1.57 (95% CI 1.37-1.81), OR = 1.24 (95% CI 1.02-1.5), and OR = 1.99 (95% CI 1.67-2.37), respectively (p < 0.001 for all, except for gastroschisis [p = 0.029]). There was no observed improvement for children with encephalocele (OR = 0.98, 95% CI 0.95-1.01, p = 0.19) and children with biliary atresia surviving with native liver (OR = 0.96, 95% CI 0.88-1.03, p = 0.26). The presence of additional structural anomalies, low birth weight, and earlier year of birth were the most commonly reported predictors of reduced survival for any congenital anomaly type. The main limitation of the meta-analysis was the small number of studies and the small size of the cohorts, which limited the predictive capabilities of the models resulting in wide confidence intervals. CONCLUSIONS: This systematic review and meta-analysis summarises estimates of long-term survival associated with major congenital anomalies. We report a significant improvement in survival of children with specific congenital anomalies over the last few decades and predict survival estimates up to 20 years of age for those born in 2020. This information is important for the planning and delivery of specialised medical, social, and education services and for counselling affected families. This trial was registered on the PROSPERO database (CRD42017074675).

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Glinianaia SV, Morris JK, Best KE, et al. Long-term survival of children born with congenital anomalies: A systematic review and meta-analysis of population-based studies. PLoS Med. 2020. PMID: 32986711. doi:10.1371/journal.pmed.1003356

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。